3rd Quarter - Report

THE MCMANUS GROUP for ALLERGAN INC

Firm
Client
Income
$70,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Extension of the research and development tax credit in H.R. 6049, "Energy and Tax Extenders Act of 2008," H.R. 7060, "Renewable Energy and Job Creation Tax Act of 2008," and S. 3335, "Jobs, Energy, Families, and Disaster Relief Act of 2008." H.R. 1424, "Emergency Economic Stabilization Act of 2008," Div. C, related to tax extenders.

LobbyistCovered position, as disclosed
JOHN MCMANUS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 6049 (110th), H.R. 1424 (110th), S. 3335 (110th), H.R. 7060 (110th)

Medicare/Medicaid MMM

Clarification of the scope of Medicaid rebates for physician-administered drugs. H.R. 6331, "Medicare Improvements for Patients and Providers Act of 2008."

LobbyistCovered position, as disclosed
JOHN MCMANUS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6331 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.